Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
49 studies found for:    Open Studies | "Helicobacter Infections"
Show Display Options
Rank Status Study
21 Recruiting Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: esomeprazole+amox+levo;   Drug: esomeprazole+bismuth+tetra+levo
22 Recruiting Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: Doxycycline;   Drug: Furazolidone;   Drug: Esomeprazole;   Drug: Colloidal Bismuth Subcitrate;   Drug: Sensitivity antibiotics
23 Recruiting Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test
Condition: Helicobacter Pylori Infection
Intervention: Drug: eradication of Helicobacter pylori
24 Recruiting Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
Conditions: Gastric Cancer;   Helicobacter Pylori Infection
Interventions: Drug: 10-day bismuth-based quadruple therapy;   Other: Placebo
25 Recruiting Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: Sequential therapy 10 days;   Drug: Sequential therapy 14 days;   Drug: Concomitant therapy 10 days;   Drug: Concomitant therapy 14 days
26 Not yet recruiting A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
Conditions: Gastritis;   Gastric Ulcer
Interventions: Biological: Antibiotic selection based on the antibiotic susceptibility testing;   Genetic: PPI selection based on the CYP2C19 gene polymorphism;   Dietary Supplement: Probiotics usage based on the 16SrRNA sequencing
27 Not yet recruiting Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection
Condition: Duodenal Ulcer
Interventions: Drug: TAK-438;   Drug: Lansoprazole;   Drug: TAK-438 Placebo;   Drug: Lansoprazole Placebo;   Drug: Bismuth-Containing Quadruple Therapy
28 Recruiting 10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication
Condition: Helicobacter Pylori Infection
Interventions: Drug: Rabeprazole Sodium 20mg;   Drug: Clarithromycin 500mg;   Drug: Amoxicillin 500 Mg
29 Recruiting Diagnosis Ability of Linked Color Imaging for Helicobacter Pylori Infection Compared With White Light Imaging
Condition: Helicobacter Pylori Infection
Intervention: Other: Esophagogastroduodenoscopy
30 Not yet recruiting 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection
Condition: Helicobacter Pylori Infection
Intervention: Drug: Esomeprazole
31 Not yet recruiting Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection
Conditions: H Pylori Infection Eradication;   Antibiotics Therapeutic Strategies;   H Pylori Eradication
Interventions: Other: Quadruple concomitant therapy treatment;   Other: Triple therapy guided by the result of the molecular resistance test
32 Recruiting Personalized Treatment for Refractory H Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: rabeprazole+3 antibiotics;   Drug: rabeprazole+bismuth+2 antibiotics;   Drug: rabeprazole+amox+tetr+levo
33 Recruiting Comparison of Two Rescue Therapies for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: esomeprazole+amox+levo+tetra;   Drug: esomeprazole+amox+levo
34 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
35 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
36 Recruiting European Registry on the Management of Helicobacter Pylori Infection
Condition: H. Pylori Infection
Intervention:
37 Recruiting Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Intervention: Drug: triple, quadruple, non-bismuth quadruple therapy
38 Recruiting Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp
Conditions: Gastric Polyp;   Helicobacter Pylori Infection
Intervention: Drug: H. pylori eradication (Amoxaxillin, Lanston, Clarithromycin)
39 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy
40 Recruiting Reinfection After Eradication of Helicobacter Pylori Infection
Conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori);   Eradication Therapy of Helicobacter Pylori;   Detection of Helicobacter Pylori
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-49) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.